Antitumor effect potentiators

Details Antitumor effect potentiators Antitumor effect potentiators

2005-08-16

2005-08-16

Dentz, Bernard (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S357000

Reexamination Certificate

active

06930115

ABSTRACT:
When used concurrently with an antitumor agent, a compound having a Rho kinase inhibitory activity, such as (R)-(+)-N-(4-pyridyl)-4-(1-aminoethyl)benzamide, reinforces an antitumor effect of the antitumor agent and is useful as an antitumor effect potentiator.Particularly, a compound having a Rho kinase inhibitory activity used with an antitumor agent in combination can reduce the dose of the antitumor agent, which in turn affords provision of a sufficient effect and/or reduction of side effects.

REFERENCES:
patent: 5906819 (1999-05-01), Kaibuchi et al.
patent: 0 956 865 (1999-11-01), None
patent: 1 064 944 (2001-01-01), None
patent: 1064944 (2001-01-01), None
patent: 1 177 796 (2002-02-01), None
patent: 8-268965 (1996-10-01), None
patent: 10-113187 (1998-05-01), None
patent: 10-201480 (1998-08-01), None
patent: 00/64478 (2000-11-01), None
patent: 97/40835 (1997-11-01), None
patent: 98/06433 (1998-02-01), None
patent: 00/64478 (2000-11-01), None
A. V. Somlyo et al., “Rho-Kinase Inhibitor Retards Migration and in vivo Dissemination of Human Prostate Cancer Cells”, Biochem. Biophys. Res. Commun., Mar. 2000, vol. 269, pp. 652-659.
K. Itoh et al., “An Essential Part for Rho-Associated Kinase in the Transcellular Invasion of Tumor Cells”, Nat. Med., 1999, vol. 5, No. 2, pp. 221-225.
T. Saito, 11. Tazai Heiyouhou. Gairon, Oct., 1988, Nippon Rinsho, No. 46 (1988, supplemental issue), pp. 254-258.
MEDLINE Abstract of Somlyo reference (Biochem. Biophys. Res. Commun., Mar. 2000, vol. 269, pp. 652-659).
MEDLINE Abstract of Itoh reference (Nat. Med., 1999, vol. 5, No. 2, pp. 221-225).
Saito reference (Nippon Rinsho, 1988, No. 46, pp. 254-258, “Cancer Therapy Manual”, this publication describes the outline of multidrug regimen in cancer chemotherapy).

Affiliated with

Also associated with

Rating

Antitumor effect potentiators does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antitumor effect potentiators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antitumor effect potentiators will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3461682